Invesco Ltd. - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$845,779
+8.9%
94,395
+36.7%
0.00%
Q2 2023$776,712
-72.0%
69,041
-71.3%
0.00%
-100.0%
Q1 2023$2,775,099
+77.7%
240,894
+78.7%
0.00%
Q4 2022$1,562,077
-10.7%
134,778
-2.1%
0.00%
-100.0%
Q3 2022$1,749,000
+2142.3%
137,737
+1114.0%
0.00%
Q2 2022$78,000
-30.4%
11,346
-3.0%
0.00%
Q1 2022$112,000
-17.6%
11,698
+2.6%
0.00%
Q4 2021$136,000
-27.3%
11,406
-1.2%
0.00%
Q3 2021$187,000
-10.5%
11,541
+15.9%
0.00%
Q2 2021$209,0009,9540.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders